These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22183774)

  • 1. Body mass index and risk of BPH: a meta-analysis.
    Wang S; Mao Q; Lin Y; Wu J; Wang X; Zheng X; Xie L
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):265-72. PubMed ID: 22183774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waist circumference and risk of lower urinary tract symptoms: a meta-analysis.
    He Q; Wang H; Yue Z; Yang L; Tian J; Liu G; Gupta S; Daneshgari F; Wang Z
    Aging Male; 2014 Dec; 17(4):223-9. PubMed ID: 25295871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of coffee intake and risk of urolithiasis.
    Wang S; Zhang Y; Mao Z; He X; Zhang Q; Zhang D
    Urol Int; 2014; 93(2):220-8. PubMed ID: 24503776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
    Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
    J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and risk of age-related cataract: a meta-analysis.
    Ye J; He J; Wang C; Wu H; Shi X; Zhang H; Xie J; Lee SY
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3885-95. PubMed ID: 22599585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
    Parsons JK; Im R
    J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of weight and obesity through life and risk of benign prostatic hyperplasia.
    Zucchetto A; Tavani A; Dal Maso L; Gallus S; Negri E; Talamini R; Franceschi S; Montella M; La Vecchia C
    Int J Obes (Lond); 2005 Jul; 29(7):798-803. PubMed ID: 15917855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract symptoms, obesity and the metabolic syndrome.
    Moul S; McVary KT
    Curr Opin Urol; 2010 Jan; 20(1):7-12. PubMed ID: 19904208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.
    Parsons JK; Kashefi C
    Eur Urol; 2008 Jun; 53(6):1228-35. PubMed ID: 18358592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study.
    Platz EA; Kawachi I; Rimm EB; Willett WC; Giovannucci E
    J Urol; 2000 Feb; 163(2):490-5. PubMed ID: 10647663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.
    Burke JP; Rhodes T; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Jul; 164(1):41-6. PubMed ID: 16611664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.